Outpace Bio

Outpace Bio

生物技术研究

Seattle,Washington 4,236 位关注者

Revolutionizing Cell Therapy with Protein Design

关于我们

Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLast?), recruit a productive immune response in the tumor microenvironment (OutSmart?), and achieve the potency (OutSpacers?), specificity (Co-LOCKR?), and safety (EGFRopt?) necessary to unlock diverse cancer indications. Outpace’s internal and partnered pipeline approach is optimized for rapid clinical validation of its technologies across diverse cell types and manufacturing processes. At Outpace Bio, we believe that the highest performing teams include people from a wide variety of backgrounds and experiences who respectfully challenge each other. We are committed to building an open, diverse, and inclusive culture for all employees.

网站
https://www.outpacebio.com
所属行业
生物技术研究
规模
51-200 人
总部
Seattle,Washington
类型
私人持股
创立
2020
领域
Cell Therapy、Protein Design、Cell Engineering、Cytokines和Immuno-oncology

地点

  • 主要

    700 Dexter Ave N

    Suite 300

    US,Washington,Seattle,98109

    获取路线

Outpace Bio员工

动态

相似主页

查看职位

融资